Antimalarial activity and sensitization of chrysosplenetin against artemisinin-resistant genotype Plasmodium berghei K173 potentially via dual-mechanism of maintaining host P-glycoprotein homeostasis mediated by NF-κB p52 or PXR/CAR signaling pathways and regulating heme/haemozoin metabolism
- PMID: 36938853
- DOI: 10.1002/ptr.7789
Antimalarial activity and sensitization of chrysosplenetin against artemisinin-resistant genotype Plasmodium berghei K173 potentially via dual-mechanism of maintaining host P-glycoprotein homeostasis mediated by NF-κB p52 or PXR/CAR signaling pathways and regulating heme/haemozoin metabolism
Abstract
This study investigated antimalarial efficacy and sensitization of chrysosplenetin against artemisinin-resistant Plasmodium berghei K173 and potential molecular mechanism. Our data indicated a risk of artemisinin resistance because a higher parasitaemia% and lower inhibition% under artemisinin treatment against resistant parasites than those in the sensitive groups were observed. Two non-antimalarial components, verapamil and chrysosplentin, being P-gp inhibitors, possessed a strong efficacy against resistant parasites but it was not the case for Bcrp inhibitor novobiocin. Artemisinin-chrysosplenetin combination improved artemisinin susceptibility of resistant P. berghei. Artemisinin activated intestinal P-gp and Abcb1/Abcg2 expressions and suppressed Bcrp whereas chrysosplenetin reversed them. Resistant parasite infection led to a decreased haemozoin in organs or an increased heme in peripheral bloods compared with the sensitives; however, that in Abcb1-deficient knockout (KO)-resistant mice reversely got increased or decreased versus wild type (WT)-resistant animals. Chrysosplenetin as well as rifampin (nuclear receptor agonist) increased the transcription levels of PXR/CAR while showed a versatile regulation on hepatic and enternal PXR/CAR in WT- or KO-sensitive or -resistant parasites. Oppositely, hepatic and enteric NF-κB p52 mRNA decreased conformably in WT but increased in KO-resistant mice. NF-κB pathway potentially involved in the mechanism of chrysosplenetin on inhibiting P-gp expressions while PXR/CAR play a more complicated role in this mechanism.
Keywords: P-glycoprotein; PXR/CAR and NF-κB p52 signal pathways; Plasmodium berghei K173; artemisinin resistance; chrysosplenetin; heme/haemozoin metabolism.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
- Alcantara, L. M., Kim, J., Moraes, C. B., Franco, C. H., Franzoi, K. D., Lee, S., Freitas-Junior, L. H., & Ayong, L. S. (2013). Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites. Experimental Parasitology, 134, 235-243.
-
- Amaratunga, C., Sreng, S., Suon, S., Phelps, E. S., Stepniewska, K., Lim, P., Zhou, C., Mao, S., Anderson, J. M., Lindegardh, N., Jiang, H., Song, J., Su, X. Z., White, N. J., Dondorp, A. M., Anderson, T. J., Fay, M. P., Mu, J., Duong, S., & Fairhurst, R. M. (2012). Artemisinin-resistant plasmodium falciparum in Pursat province, western Cambodia: A parasite clearance rate study. The Lancet Infectious Diseases, 12, 851-858.
-
- Bentires-Alj, M., Barbu, V., Fillet, M., Chariot, A., Relic, B., Jacobs, N., Gielen, J., Merville, M. P., & Bours, V. (2003). NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 22, 90-97.
-
- Birnbaum, J., Scharf, S., Schmidt, S., Jonscher, E., Hoeijmakers, W. A. M., Flemming, S., Toenhake, C. G., Schmitt, M., Sabitzki, R., Bergmann, B., Fröhlke, U., Mesén-Ramírez, P., Blancke Soares, A., Herrmann, H., Bártfai, R., & Spielmann, T. (2020). A Kelch 13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites. Science, 367(6473), 51-59.
-
- Burk, O., Arnold, K. A., Geick, A., Tegude, H., & Eichelbaum, M. (2005). A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biological Chemistry, 386, 503-513.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources